Discussing hBD-2 immunoreactivity, considered a useful marker to identify some clinical forms of psoriasis requiring differential diagnosis from DA, the interesting result was that IL-4, but not IL-13, early inhibited its epidermal expression, demonstrating the specificity of the downstream effects induced by each Th2 cytokine. This evidence concerns the gene IL4 and psoriasis.